Invasive Group B Streptococcal Disease in South Africa: Importance of Surveillance Methodology

Data on neonatal group B streptococcal (GBS) invasive disease burden are needed to refine prevention policies. Differences in surveillance methods and investigating for cases can lead to varying disease burden estimates. We compared the findings of laboratory-based passive surveillance for GBS disea...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2016-04, Vol.11 (4), p.e0152524-e0152524
Main Authors: Quan, Vanessa, Verani, Jennifer R, Cohen, Cheryl, von Gottberg, Anne, Meiring, Susan, Cutland, Clare L, Schrag, Stephanie J, Madhi, Shabir A
Format: Article
Language:English
Subjects:
Adult
Age
Antibiotics
Biology and Life Sciences
Births
Data processing
Demographic aspects
Diagnostic systems
Disease control
Disease prevention
Epidemiological Monitoring
Epidemiology
Female
Health care
Health sciences
HIV
Hospitals
Human immunodeficiency virus
Humans
Illnesses
Incidence
Laboratories
Live Birth
Medical research
Medicine and Health Sciences
Neonates
Newborn babies
Pathogens
People and places
Pregnancy
Pregnancy Complications, Infectious - epidemiology
Pregnancy Complications, Infectious - prevention & control
Prevalence studies (Epidemiology)
Real time
Research and Analysis Methods
Risk factors
Sepsis
South Africa - epidemiology
Streptococcal infections
Streptococcal Infections - epidemiology
Streptococcal Infections - prevention & control
Streptococcal Vaccines - administration & dosage
Streptococcus
Streptococcus agalactiae
Streptococcus infections
Surveillance
Systematic review
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Data on neonatal group B streptococcal (GBS) invasive disease burden are needed to refine prevention policies. Differences in surveillance methods and investigating for cases can lead to varying disease burden estimates. We compared the findings of laboratory-based passive surveillance for GBS disease across South Africa, and for one of the provinces compared this to a real-time, systematic, clinical surveillance in a population-defined region in Johannesburg, Soweto. Passive surveillance identified a total of 799 early-onset disease (EOD,
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0152524